Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 11;14(6):1454. doi: 10.3390/cancers14061454

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Left to right: ¹⁷⁷Lu-J591 anterior and posterior whole-body images 7 days after ¹⁷⁷Lu-J591 administration, and Technetium 99m-methyl diphosphonate (^99mTc-MDP) bone scan anterior and posterior whole-body images, showing ¹⁷⁷Lu-J591 targeting of extensive bone and soft-tissue metastases. Reprinted with permission from: Tagawa S.T, et al. Phase 1/2 Study of Fractionated Dose Lutetium-177–Labeled Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 (¹⁷⁷Lu-J591) for Metastatic Castration-Resistant Prostate Cancer. Cancer, 2019 Aug 1; 125 (15): 2561–2569 [97].